(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
(Date:11/19/2009)...-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), a...er to its shareholders, discussing the Company,s a...aceuticals Holdings, Inc. (CHBP), an integrated bi...ublic of China. The merger gives NeoStem a control.... Ltd., CHBP,s primary operating subsidiary and a ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4...lant to Provide an Attractive Domestic Alternative...y 18 Fulcrum BioEnergy, Inc.,today announced that...n,with its plans to build one of the first commerc...icipal solid waste to ethanol. The plant will,proc...olutionizing waste,disposal while creating a much ...
...ignificantly Strengthens Teva,s Market Leadership ...n Key Global Markets, Acquisition Expected to Be ...RUSALEM and MONTVALE, N.J., July 18 Teva,Pharmace...harmaceuticals,Inc. (NYSE: BRL ) announced today ... which Teva will acquire Barr, the fourth largest ...
... CAMBRIDGE, Mass., July 17, 2008 -- The Defense A...ed a $1.2 million grant to an interdisciplinary te...ace enhanced Raman scattering (SERS) for the first... phases of the development program are completed, ... million in funding. , Ken Crozier, Assistant Pro...
Other Biology Technology:Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock 2Fulcrum BioEnergy Announces Plans to Build One of the First Commercial-Scale Ethanol Plants Using Municipal Solid Waste as Feedstock 3Teva to Acquire Barr 2Teva to Acquire Barr 3Teva to Acquire Barr 4Teva to Acquire Barr 5Teva to Acquire Barr 6Teva to Acquire Barr 7Teva to Acquire Barr 8DARPA awards research team $1.2M grant to study surface enhanced Raman scattering 2... scientists offer a compendium of air pollution re...n humans and the environment, while addressing the... fire as a land management tool. , The 686-page b...rts from various science disciplines who studied s...sia, and Australia from prehistoric times to the p...
... toward winter, many people will begin to experien...evastating. , About 6 percent of the U.S. popula...SAD, a sometimes-debilitating depression that begi...rers may even find it difficult to get out of bed ... understood, is often treated with "light therapy,...
...t cheap piece of scrap iron before you toss it in .... Someday soon, much of the world might also. , Z...eering, recently concluded a five-year research pr...versity in Shanghai used two million pounds of iro... , The project, carried out in Shanghai, was the ...
Other Biology News:Book explores global implications of wildland fire smoke 2Seasonal affective disorder may be linked to genetic mutation, study suggests 2A green future for scrap iron 2A green future for scrap iron 3Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-NF-kB p65, phospho (Ser345) Antibody, Unconjugated from Spring Bioscience
Anti-NSP-C (Neuroendocrine-Specific-Protein) Monoclonal Antibody, Unconjugated, Clone RNL-4 from CHEMICON
Rabbit Anti-Human ADAMTS-4, disintegrin-like domain Antibody, Unconjugated from CHEMICON
Biology Products: